ARS Pharma insider plans $368K stock sale

Rhea-AI Filing Summary

ARS Pharmaceuticals, Inc. (SPRY) is named as the issuer in a Form 144 notice filed on behalf of Sarina Tanimoto, covering proposed sales of company common stock under Rule 144. The filing lists 63,289 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $368,099.12, and an SEC file number of 001-39756. The notice also reports that during the prior three months Sarina Tanimoto sold 25,000 shares of common stock for $147,970.00 on 08/20/2026, 25,000 shares for $161,170.00 on 08/19/2026, and 49,401 shares for $311,191.72 on 08/18/2026. The proposed new sale is associated with a stock option exercise for cash as of 08/31/2026.

Key Figures

Shares to be sold: 63,289 shares of common stock Aggregate market value of proposed sale: $368,099.12 Prior sale on 08/20/2026: 25,000 shares; $147,970.00 +4 more

7 metrics

Shares to be sold 63,289 shares of common stock Proposed sale under Rule 144 via Morgan Stanley Smith Barney LLC

Aggregate market value of proposed sale $368,099.12 Value associated with 63,289 shares of common stock

Prior sale on 08/20/2026 25,000 shares; $147,970.00 Common stock sold by Sarina Tanimoto during past 3 months

Prior sale on 08/19/2026 25,000 shares; $161,170.00 Common stock sold by Sarina Tanimoto during past 3 months

Prior sale on 08/18/2026 49,401 shares; $311,191.72 Common stock sold by Sarina Tanimoto during past 3 months

SEC file number 001-39756 SEC file number for ARS Pharmaceuticals, Inc.

Form 144 date 08/31/2026 Date associated with securities to be sold and signature

Key Terms

Rule 144, Form 144, Stock Option Exercise, Securities To Be Sold, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 08/31/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities To Be Sold financial

"144: Securities To Be Sold Common | 08/31/2026"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months SARINA TANIMOTO"

FAQ

What does the Form 144 filing for SPRY by Sarina Tanimoto disclose?

The Form 144 for ARS Pharmaceuticals, Inc. (SPRY) discloses a proposed sale by Sarina Tanimoto of 63,289 shares of common stock under Rule 144, with an aggregate market value of $368,099.12, to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many SPRY shares are proposed to be sold under this Form 144?

The notice lists 63,289 shares of ARS Pharmaceuticals, Inc. common stock proposed to be sold, with an aggregate market value shown as $368,099.12, in connection with a stock option exercise for cash dated 08/31/2026.

Which broker is named in the SPRY Form 144 for the proposed sale?

The Form 144 indicates that the 63,289 shares of ARS Pharmaceuticals, Inc. common stock are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What prior SPRY stock sales by Sarina Tanimoto are reported in the last three months?

The filing reports three prior sales of ARS Pharmaceuticals, Inc. common stock: 25,000 shares for $147,970.00 on 08/20/2026, 25,000 shares for $161,170.00 on 08/19/2026, and 49,401 shares for $311,191.72 on 08/18/2026.

What is the relationship between the proposed SPRY sale and stock options?

The Form 144 states that the 63,289 shares of ARS Pharmaceuticals, Inc. common stock to be sold are related to a Stock Option Exercise, with the transaction type shown as “Stock Option Exercise” and consideration type as “Cash” dated 08/31/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:09 PM Accepted by SEC EDGAR 08/31/2026 - 04:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001951291
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARS PHARMACEUTICALS, INC.
SEC File Number	001-39756
Address of Issuer	11682 El Camino Real Suite 300 San Diego CALIFORNIA 92130
Phone	(858) 771-9307
Name of Person for Whose Account the Securities are To Be Sold	SARINA TANIMOTO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	63289	368099.12	99447343	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2026	Stock Option Exercise	Issuer			63289	08/31/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SARINA TANIMOTO 11682 El Camino Real Suite 300 San Diego CA 92130	Common	08/20/2026	25000	147970.00
SARINA TANIMOTO 11682 El Camino Real Suite 300 San Diego CA 92130	Common	08/19/2026	25000	161170.00
SARINA TANIMOTO 11682 El Camino Real Suite 300 San Diego CA 92130	Common	08/18/2026	49401	311191.72

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sarina Tanimoto
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)